Views & Analysis | Perspectives on pharma industry issues

R&D

Inspection readiness is now a commercial question

Manufacturers of advanced therapies are discovering that a digital quality system does more than satisfy inspectors.

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

Articles

mHealth Monthly Mashup: release 1.0 - an introductory mHeal...

Commencing his new monthly series, Michael Spitz warmly introduces us to the world of mobile health technology. Welcome to the mHealth Monthly Mashup on pharmaphorum, with your host Michael Spitz, VP of Digital Strategy at Ignite Health in...

Articles

The bribery act 2010 – what do you do if your adequate proce...

With the recent Bribery Act coming into force, Richard Sallybanks details steps we can take to help prevent bribery by ‘associated’ persons. Much has already been written about the Bribery Act which comes into force on 1 July 2011, in particular the new criminal offence for...

Articles

Pharma emerging markets: clinical research management in Lat...

Valentina Jaramillo returns with her Latin America series, this time joined by Carlos Pinzon to address clinical research management. Technological advances and training of human resources in clinical research have made of research a potential process of…

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.